The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog is intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at www.Vicus.com, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Support this site

    If you found the information here helpful, please consider supporting this site.If you found the information here helpful, please consider supporting this site.

  • Recent Posts

  • Recent Comments

Archive for July, 2012

The end of tanning parlors

Tuesday, July 24th, 2012

In the ‘70s, commercial tanning beds were introduced. In less than 3 decades, over half of adults in northern Europe reported using them.

Now, growing evidence of health risks is leading to restricted access to indoor tanning, worldwide. (more…)

What’s trending now in visits to homeopaths

Saturday, July 21st, 2012

Two recent studies report marked differences in the use of homeopathy.

First, homeopathy in the US. (more…)

Smart acupuncture

Friday, July 20th, 2012

Fast Company reports that a new system links to a readout and shows how much electrical activity the needles are stimulating in a patient’s muscles. (more…)

Milk thistle fails in study of Hep C treatment

Wednesday, July 18th, 2012

Silymarin (Silybium marianum), an extract of milk thistle, is often used to treat chronic liver disease.

Researchers with the Silymarin in the NASH and C Hepatitis (SyNCH) Study Group studied its effect when combined with interferon. (more…)